• / Free eNewsletters & Magazine
  • / My Account
Home>Insiders>Ian C. Read

Ian C. Read

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. Pfizer to Acquire Medivation in Deal Worth $14 Billion -- Update

    Pfizer to Acquire Medivation in Deal Worth $14 Billion -- Update

  2. Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 2nd Update

    Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 2nd Update

  3. Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal

    Pfizer Adds Key Cancer Drug in $14 Billion Biotech Deal

  4. Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 4th Update

    Pfizer to Acquire Medivation in Deal Worth $14 Billion -- 4th Update

  5. UPDATE: Medivation's stock soars after Pfizer buyout deal

    UPDATE: Medivation's stock soars after Pfizer buyout deal

  6. Pfizer Nears Agreement to Buy Medivation, Sources Say -- Update

    Pfizer Nears Agreement to Buy Medivation, Sources Say -- Update

  7. Pfizer Nears Agreement to Buy Medivation

    Pfizer Nears Agreement to Buy Medivation

  8. Pfizer Near $14 Billion Deal for Biotech -- WSJ

    Pfizer Near $14 Billion Deal for Biotech -- WSJ

  9. Business Groups Sue U.S. Government Over Tax-Inversion Rules -- 2nd Update

    Business Groups Sue U.S. Government Over Tax-Inversion Rules -- 2nd Update

  10. Wall Street wants answers on a potential Pfizer split, but Pfizer won't give one yet

    Wall Street wants answers on a potential Pfizer split, but Pfizer won't give one yet

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.